Lymphadenectomy extent and survival of patients with gastric carcinoma: A systematic review and meta-analysis of time-to-event data from randomized trials

Cancer Treatment Reviews

Volumn 41, Issue 5, 2015, Pages 448-454

  Mocellin, Simone ^a   Nitti, Donato ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Gastric cancer; Lymph node dissection; Lymphadenectomy; Meta analysis; Randomized controlled trial; Survival

Indexed keywords

DISEASE FREE SURVIVAL; DISEASE SPECIFIC SURVIVAL; HUMAN; LYMPH NODE DISSECTION; META ANALYSIS; OVERALL SURVIVAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STOMACH CARCINOMA; SURGICAL MORTALITY; SYSTEMATIC REVIEW; ADENOCARCINOMA; LYMPH NODE METASTASIS; MORTALITY; PATHOLOGY; PROCEDURES; STOMACH NEOPLASMS;

ADENOCARCINOMA; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STOMACH NEOPLASMS;

EID: 84937512218     PISSN: 03057372     EISSN: 15321967     Source Type: Journal    
DOI: 10.1016/j.ctrv.2015.03.003     Document Type: Review

References (40)

1. Ferlay J., Soerjomataram I., Dikshit R., Eser S., Mathers C., Rebelo M., et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2014, 136:E359-E386.
2. Hartgrink H.H., Jansen E.P., van Grieken N.C., van de Velde C.J. Gastric cancer. Lancet 2009, 374:477-490.
3. Wadhwa R., Song S., Lee J.S., Yao Y., Wei Q., Ajani J.A. Gastric cancer-molecular and clinical dimensions. Nat Rev Clin Oncol 2013, 10:643-655.
4. Zhang J., Zhou Y., Jiang K., Shen Z., Ye Y., Wang S. Evaluation of the seventh AJCC TNM staging system for gastric cancer: a meta-analysis of cohort studies. Tumour Biol 2014, 35:8525-8532.
5. Dikken J.L., Verheij M., Cats A., Jansen E.P., Hartgrink H.H., van de Velde C.J. Extended lymph node dissection for gastric cancer from a European perspective. Gastric Cancer 2011, 14:396-398.
6. Giuliani A., Miccini M., Basso L. Extent of lymphadenectomy and perioperative therapies: two open issues in gastric cancer. World J Gastroenterol 2014, 20:3889-3904.
7. Brar S., Law C., McLeod R., Helyer L., Swallow C., Paszat L., et al. Defining surgical quality in gastric cancer: a RAND/UCLA appropriateness study. J Am Coll Surg 2013, 217(347-57):e1.
8. Allum W.H. Optimal surgery for gastric cancer: is more always better?. Recent Results Cancer Res 2012, 196:215-227.
9. Russell M.C., Mansfield P.F. Surgical approaches to gastric cancer. J Surg Oncol 2013, 107:250-258.
10. Schmidt B., Yoon S.S. D1 versus D2 lymphadenectomy for gastric cancer. J Surg Oncol 2013, 107:259-264.
11. Wong J., Jackson P. Gastric cancer surgery: an American perspective on the current options and standards. Curr Treat Options Oncol 2011, 12:72-84.
12. Verlato G., Giacopuzzi S., Bencivenga M., Morgagni P., De Manzoni G. Problems faced by evidence-based medicine in evaluating lymphadenectomy for gastric cancer. World J Gastroenterol 2014, 20:12883-12891.
13. Liberati A., Altman D.G., Tetzlaff J., Mulrow C., Gotzsche P.C., Ioannidis J.P., et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009, 339:b2700.
14. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0: The Cochrane Collaboration (available from); 2011. http://www.cochrane-handbook.org.
15. Guyatt G.H., Oxman A.D., Schunemann H.J., Tugwell P., Knottnerus A. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol 2011, 64:380-382.
16. Parmar M.K., Torri V., Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 1998, 17:2815-2834.
17. Altman D.G., Andersen P.K. Calculating the number needed to treat for trials where the outcome is time to an event. BMJ 1999, 319:1492-1495.
18. Dent D.M., Madden M.V., Price S.K. Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma. Br J Surg 1988, 75:110-112.
19. Kulig J., Popiela T., Kolodziejczyk P., Sierzega M., Szczepanik A. Standard D2 versus extended D2 (D2+) lymphadenectomy for gastric cancer: an interim safety analysis of a multicenter, randomized, clinical trial. Am J Surg 2007, 193:10-15.
20. Galizia G., Lieto E., De Vita F., Castellano P., Ferraraccio F., Zamboli A., et al. Modified versus standard D2 lymphadenectomy in total gastrectomy for nonjunctional gastric carcinoma with lymph node metastasis. Surgery 2015, 157:285-296.
21. Degiuli M., Sasako M., Ponti A., Vendrame A., Tomatis M., Mazza C., et al. Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer. Br J Surg 2014, 101:23-31.
22. Wu C.W., Hsiung C.A., Lo S.S., Hsieh M.C., Chen J.H., Li A.F., et al. Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol 2006, 7:309-315.
23. Songun I., Putter H., Kranenbarg E.M., Sasako M., van de Velde C.J. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol 2010, 11:439-449.
24. Sasako M., Sano T., Yamamoto S., Kurokawa Y., Nashimoto A., Kurita A., et al. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med 2008, 359:453-462.
25. Cuschieri A., Weeden S., Fielding J., Bancewicz J., Craven J., Joypaul V., et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 1999, 79:1522-1530.
26. Robertson C.S., Chung S.C., Woods S.D., Griffin S.M., Raimes S.A., Lau J.T., et al. A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. Ann Surg 1994, 220:176-182.
27. Yonemura Y., Wu C.C., Fukushima N., Honda I., Bandou E., Kawamura T., et al. Randomized clinical trial of D2 and extended paraaortic lymphadenectomy in patients with gastric cancer. Int J Clin Oncol 2008, 13:132-137.
28. Maeta M., Yamashiro H., Saito H., Katano K., Kondo A., Tsujitani S., et al. A prospective pilot study of extended (D3) and superextended para-aortic lymphadenectomy (D4) in patients with T3 or T4 gastric cancer managed by total gastrectomy. Surgery 1999, 125:325-331.
29. NCCN. Gastric Cancer. National Comprehensive Cancer Network Guidelines (); 2015. http://www.nccn.org.
30. El-Sedfy A., Dixon M., Seevaratnam R., Bocicariu A., Cardoso R., Mahar A., et al. Personalized surgery for gastric adenocarcinoma: a meta-analysis of D1 versus D2 lymphadenectomy. Ann Surg Oncol 2014.
31. Jiang L., Yang K.H., Guan Q.L., Zhao P., Chen Y., Tian J.H. Survival and recurrence free benefits with different lymphadenectomy for resectable gastric cancer: a meta-analysis. J Surg Oncol 2013, 107:807-814.
32. Jiang L., Yang K.H., Chen Y., Guan Q.L., Zhao P., Tian J.H., et al. Systematic review and meta-analysis of the effectiveness and safety of extended lymphadenectomy in patients with resectable gastric cancer. Br J Surg 2014, 101:595-604.
33. Seevaratnam R., Bocicariu A., Cardoso R., Mahar A., Kiss A., Helyer L., et al. A meta-analysis of D1 versus D2 lymph node dissection. Gastric Cancer 2012, 15(Suppl. 1):S60-S69.
34. Memon M.A., Subramanya M.S., Khan S., Hossain M.B., Osland E., Memon B. Meta-analysis of D1 versus D2 gastrectomy for gastric adenocarcinoma. Ann Surg 2011, 253:900-911.
35. McCulloch P., Nita M.E., Kazi H., Gama-Rodrigues J.J. WITHDRAWN: extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach. Cochrane Database Syst Rev 2012, 1:CD001964.
36. Yang S.H., Zhang Y.C., Yang K.H., Li Y.P., He X.D., Tian J.H., et al. An evidence-based medicine review of lymphadenectomy extent for gastric cancer. Am J Surg 2009, 197:246-251.
37. Cuschieri S.A., Hanna G.B. Meta-analysis of D1 versus D2 gastrectomy for gastric adenocarcinoma: let us move on to another era. Ann Surg 2014, 259:e90.
38. Oba K., Paoletti X., Alberts S., Bang Y.J., Benedetti J., Bleiberg H., et al. Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: a meta-analysis. J Natl Cancer Inst 2013, 105:1600-1607.
39. Wang Z., Chen J.Q., Cao Y.F. Systematic review of D2 lymphadenectomy versus D2 with para-aortic nodal dissection for advanced gastric cancer. World J Gastroenterol 2010, 16:1138-1149.
40. Chen X.Z., Hu J.K., Zhou Z.G., Rui Y.Y., Yang K., Wang L., et al. Meta-analysis of effectiveness and safety of D2 plus para-aortic lymphadenectomy for resectable gastric cancer. J Am Coll Surg 2010, 210:100-105.